The purpose of this study was to explore the value of pre‐treatment levels of CD3+CD56+ NKT cells and CD19+ B cells in evaluating the relapse of patients with neuromyelitis optica… Click to show full abstract
The purpose of this study was to explore the value of pre‐treatment levels of CD3+CD56+ NKT cells and CD19+ B cells in evaluating the relapse of patients with neuromyelitis optica spectrum disorders (NMOSD) treated with rituximab.
Keywords:
cd19 cells;
neuromyelitis optica;
treated rituximab;
optica spectrum;
cd3 cd56;
cd56 nkt
Journal Title: Brain and Behavior
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!